Acurx Pharmaceuticals, Inc.

  • Home
  • About
    • Management / Consultants
    • Scientific / Corporate Advisors
    • Board of Directors
  • Pipeline
    • Overview
    • Ibezapolstat
    • GPSS®
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Videos
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

ALERT: NEW ARTICLE

IDSA Clinical Infectious Diseases; Emergence and spread of Clostridioides difficile Isolates with Reduced Fidaxomicin Susceptibility in an Acute Care Hospital

Read Publication

Continue

Financial Results

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed

  • Financial Information

  • Overview
  • Financial Results
  • Balance Sheet
  • Income Statement
  • Cash Flow

2025

Q2 2025

Quarter Ended Jun 30, 2025
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q1 2025

Quarter Ended Mar 31, 2025
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

2024

FY 2024

Fiscal Year Ended Dec 31, 2024
PDF HTML
Earnings Release
PDF HTML
10-K Filing
ZIP XLS HTML
XBRL

Q3 2024

Quarter Ended Sep 30, 2024
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q2 2024

Quarter Ended Jun 30, 2024
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q1 2024

Quarter Ended Mar 31, 2024
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

2023

FY 2023

Fiscal Year Ended Dec 31, 2023
PDF HTML
Earnings Release
PDF HTML
10-K Filing
ZIP XLS HTML
XBRL

Q3 2023

Quarter Ended Sep 30, 2023
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q2 2023

Quarter Ended Jun 30, 2023
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q1 2023

Quarter Ended Mar 31, 2023
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

2022

FY 2022

Fiscal Year Ended Dec 31, 2022
PDF HTML
Earnings Release
PDF HTML
10-K Filing
ZIP XLS HTML
XBRL

Q3 2022

Quarter Ended Sep 30, 2022
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q2 2022

Quarter Ended Jun 30, 2022
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q1 2022

Quarter Ended Mar 31, 2022
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

2021

FY 2021

Fiscal Year Ended Dec 31, 2021
PDF HTML
Earnings Release
PDF HTML
10-K Filing
ZIP XLS HTML
XBRL

Q3 2021

Quarter Ended Sep 30, 2021
PDF HTML
Earnings Release
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL

Q2 2021

Quarter Ended Jun 30, 2021
PDF HTML
Earnings Release
Audio
Earnings Webcast
PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
© 2025 Acurx Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap